azomycin has been researched along with Carcinoma in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (40.00) | 18.7374 |
1990's | 3 (15.00) | 18.2507 |
2000's | 5 (25.00) | 29.6817 |
2010's | 4 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aishima, S; Kaneki, M; Kitajima, Y; Nakamura, J; Noshiro, H; Tanaka, T; Wakiyama, K; Yanagihara, K | 1 |
Cao, H; Chen, X; Chen, Y; Fan, J; Fu, S; Lin, S; Ren, P; Su, Z; Sun, X; Wu, J; Yang, B; Yang, L; Zhang, Y; Zhou, J; Zhou, Y; Zou, X | 1 |
Cook, GJ; Fong, KW; Goh, V; Tan, T; Wee, J; Yip, C | 1 |
Busk, M; Bussink, J; Engelholm, SA; Hansen, AE; Jørgensen, JT; Kjær, A; Kristensen, AT; McEvoy, FJ; van der Kogel, AJ | 1 |
Aquino-Parsons, C; Chou, SC; Davidson, SE; Havsteen, H; Hunter, R; Ladekarl, M; Lindegaard, JC; Loncaster, J; Nordsmark, M; Overgaard, J; Raleigh, JA; Varia, M; West, C | 1 |
De Bast, M; Gillart, J; Gregoire, V; Labar, D; Leveque, PH; Mahy, P; Marchand, J | 1 |
Byhardt, RW; Cox, JD; Greenberg, M; Komaki, R | 1 |
Anderson, PJ; Bennett, MH; Dische, S; Saunders, MI | 1 |
Brown, DM; Brown, JM; Lee, WW; Yu, NY | 1 |
Adams, GE; Ahmed, I; Chaplin, DJ; Sheldon, PW; Stratford, IJ | 1 |
Arnold, EP; Bailey, C; Burry, AF; Bydder, PV; Firth, LA; Gowland, S; Gray, AJ; Mcllroy, R | 1 |
Denekamp, J; Hirst, DG; Stewart, FA; Terry, NH | 1 |
Hodgkiss, RJ; Webster, L; Wilson, GD | 1 |
Adams, GE; Butler, SA; Cole, SM; Sansom, JM; Stratford, IJ; Szabo, C; Thiemermann, C; Wood, PJ | 1 |
Aboagye, EO; Griffiths, JR; Horsman, MR; Lewis, AD; Maxwell, RJ; Tracy, M; Workman, P | 1 |
Beasley, NJ; Harris, AL; Maxwell, PH; Pastorek, J; Pugh, CW; Ratcliffe, PJ; Sibtain, A; Talks, KL; Turley, H; Turner, KJ; Watson, PH; Wilson, GD; Wykoff, CC | 1 |
Chou, SC; Davidson, SE; Havsteen, H; Hunter, R; Lindegaard, JC; Loncaster, J; Nordsmark, M; Overgaard, J; Raleigh, JA; Varia, M; West, C | 1 |
Banáth, JP; Durand, RE; Olive, PL | 1 |
Adams, GE; Dische, S; Flockhart, IR; Foster, JL; Gray, AJ | 1 |
2 review(s) available for azomycin and Carcinoma
Article | Year |
---|---|
Clinical significance of hypoxia in nasopharyngeal carcinoma with a focus on existing and novel hypoxia molecular imaging.
Topics: Biomarkers, Tumor; Carcinoma; Cell Hypoxia; Coordination Complexes; Humans; Magnetic Resonance Imaging; Molecular Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nitroimidazoles; Organometallic Compounds; Oxygen; Positron-Emission Tomography; Prognosis; Thiosemicarbazones; Tomography, Emission-Computed, Single-Photon | 2016 |
Radiation sensitizers.
Topics: Animals; Antineoplastic Agents; Bromodeoxycytidine; Bromodeoxyuridine; Carcinoma; Deoxyuridine; Dogs; Dose-Response Relationship, Radiation; Floxuridine; Humans; Hypoxia; Idoxuridine; Lung Neoplasms; Methotrexate; Metronidazole; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Research; Sarcoma, Experimental; Skin | 1976 |
3 trial(s) available for azomycin and Carcinoma
Article | Year |
---|---|
Primary tumor control after radiotherapy for carcinoma of the bronchus.
Topics: Bronchial Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Clinical Trials as Topic; Double-Blind Method; Humans; Misonidazole; Neoplasm Metastasis; Nitroimidazoles; Radiation Tolerance | 1984 |
A national trial on the treatment of invasive bladder cancer.
Topics: Carcinoma; Clinical Trials as Topic; Humans; Misonidazole; Nausea; Neoplasm Staging; New Zealand; Nitroimidazoles; Urinary Bladder Neoplasms; Vomiting | 1981 |
Clinical testing of the radiosensitiser Ro-07-0582. I. Dose tolerance, serum and tumour concentrations.
Topics: Adult; Aged; Biopsy; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Humans; Middle Aged; Nausea; Neoplasm Metastasis; Nervous System Diseases; Neurologic Examination; Nitroimidazoles; Radiation-Sensitizing Agents; Radiography; Sarcoma; Skull; Taste; Vomiting | 1976 |
15 other study(ies) available for azomycin and Carcinoma
Article | Year |
---|---|
Low-dose YC-1 combined with glucose and insulin selectively induces apoptosis in hypoxic gastric carcinoma cells by inhibiting anaerobic glycolysis.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetyl Coenzyme A; Anaerobiosis; Animals; Apoptosis; Carcinoma; Cell Line, Tumor; Deoxyguanosine; Glucose; Glucose Transporter Type 1; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Insulin; Mice; Nitroimidazoles; Oxidative Phosphorylation; Stomach Neoplasms; Tumor Hypoxia; Xenograft Model Antitumor Assays | 2017 |
Synergistic effect of combination topotecan and chronomodulated radiation therapy on xenografted human nasopharyngeal carcinoma.
Topics: Animals; Carcinoma; Cell Hypoxia; Chronotherapy; Combined Modality Therapy; DNA Damage; DNA Topoisomerases, Type I; Dose-Response Relationship, Radiation; Histones; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Nitroimidazoles; Phosphorylation; Radiation Tolerance; Radiation-Sensitizing Agents; Time Factors; Topoisomerase I Inhibitors; Topotecan; Transplantation, Heterologous | 2013 |
(64)Cu-ATSM and (18)FDG PET uptake and (64)Cu-ATSM autoradiography in spontaneous canine tumors: comparison with pimonidazole hypoxia immunohistochemistry.
Topics: Animals; Autoradiography; Carcinoma; Cell Hypoxia; Coordination Complexes; Copper Radioisotopes; Dogs; Fluorodeoxyglucose F18; Immunohistochemistry; Nitroimidazoles; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Thiosemicarbazones | 2012 |
Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas.
Topics: Adolescent; Adult; Analysis of Variance; Carcinoma; Cell Hypoxia; Computer Graphics; Female; Humans; Microelectrodes; Nitroimidazoles; Oxygen; Polarography; Radiation-Sensitizing Agents; Retrospective Studies; Statistics, Nonparametric; Uterine Cervical Neoplasms | 2003 |
Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)- N-(3,3,3-[(18)F]trifluoropropyl)acetamide, [(18)F]EF3.
Topics: Animals; Carcinoma; Cell Hypoxia; Cell Line, Tumor; Drug Evaluation, Preclinical; Fibrosarcoma; Male; Metabolic Clearance Rate; Mice; Mice, Inbred C3H; Nitroimidazoles; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2004 |
Reduced fractionation and the potential of hypoxic cell sensitizers in irradiation of malignant epithelial tumors.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Humans; Lung Neoplasms; Misonidazole; Mouth Neoplasms; Nitroimidazoles; Oropharynx; Pharyngeal Neoplasms; Radiation-Sensitizing Agents; Radiotherapy Dosage; Retrospective Studies | 1980 |
SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use.
Topics: Animals; Carcinoma; Cell Line; Central Nervous System; Cricetinae; Dogs; Etanidazole; Female; In Vitro Techniques; Lipid Metabolism; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; X-Rays | 1981 |
Radiosensitization in vivo: a study with an homologous series of 2-nitroimidazoles.
Topics: Animals; Carcinoma; Cell Survival; Cells, Cultured; Drug Evaluation, Preclinical; Lung Neoplasms; Mice; Mice, Inbred C57BL; Nitroimidazoles; Radiation-Sensitizing Agents; Structure-Activity Relationship; Time Factors | 1983 |
Is tumour radiosensitization by misonidazole a general phenomenon?
Topics: Animals; Carcinoma; Cell Line; Dose-Response Relationship, Radiation; Male; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation Tolerance; Sarcoma, Experimental; Time Factors | 1980 |
Development of bioreductive markers for tumour hypoxia.
Topics: Animals; Antibodies; Antibodies, Monoclonal; Caffeine; Carcinoma; Cell Division; Cell Hypoxia; Cell Line; DNA, Neoplasm; Mice; Mice, Inbred CBA; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; Theophylline; Tumor Cells, Cultured | 1995 |
Induction of hypoxia in experimental murine tumors by the nitric oxide synthase inhibitor, NG-nitro-L-arginine.
Topics: Animals; Arginine; Carcinoma; Cell Hypoxia; Cell Survival; Drug Screening Assays, Antitumor; Drug Synergism; Energy Metabolism; Female; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred C3H; Nitroarginine; Nitroimidazoles; Phosphates; Prodrugs; Sarcoma, Experimental | 1994 |
The relationship between tumour oxygenation determined by oxygen electrode measurements and magnetic resonance spectroscopy of the fluorinated 2-nitroimidazole SR-4554.
Topics: Animals; Carcinoma; Cell Hypoxia; Fluorine Radioisotopes; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Molecular Probes; Nitroimidazoles; Oxygen | 1998 |
Hypoxia-inducible expression of tumor-associated carbonic anhydrases.
Topics: Blotting, Western; Carbonic Anhydrases; Carcinoma; Carcinoma, Renal Cell; DNA-Binding Proteins; Endothelial Growth Factors; Genes, Reporter; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoblotting; Immunohistochemistry; In Situ Hybridization; Kidney Neoplasms; Lymphokines; Models, Genetic; Necrosis; Nitroimidazoles; Nuclear Proteins; Oxygen; Plasmids; Promoter Regions, Genetic; Radiation-Sensitizing Agents; RNA; RNA, Messenger; Skin Neoplasms; Transcription Factors; Tumor Cells, Cultured; Up-Regulation; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Cell Hypoxia; Female; Humans; Middle Aged; Nitroimidazoles; Oxygen; Partial Pressure; Radiation-Sensitizing Agents; Uterine Cervical Neoplasms | 2001 |
The range of oxygenation in SiHa tumor xenografts.
Topics: Animals; Carcinoma; Cell Survival; Comet Assay; DNA Damage; Female; Humans; In Vitro Techniques; Mice; Mice, Inbred NOD; Mice, SCID; Misonidazole; Nitroimidazoles; Oxygen Consumption; Radiation-Sensitizing Agents; Transplantation, Heterologous; Uterine Cervical Neoplasms | 2002 |